A carregar...
Histone deacetylase inhibitors as cancer therapeutics
Cancer cells contain significant alterations in their epigenomic landscape, which several enzyme families reversibly contribute to. One class of epigenetic modifying enzymes is that of histone deacetylases (HDAC), which are receiving considerable scrutiny clinically as a therapeutic target in many c...
Na minha lista:
| Publicado no: | Ann Transl Med |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4980376/ https://ncbi.nlm.nih.gov/pubmed/27568481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.07.22 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|